Search

Search Constraints

You searched for: Author/Creator Wang, Jessie

Search Results

3. A large multicentre, randomized, double‐blind, cross‐over study in healthy volunteers to compare pharmacokinetics, pharmacodynamics and safety of a pegfilgrastim biosimilar with its US‐ and EU‐reference biologics. Issue 6 (21st February 2020)

4. Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects. (10th January 2013)

5. Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study. Issue 10182 (27th April 2019)

6. Effect of extremes of body weight on the pharmacokinetics, pharmacodynamics, safety and tolerability of apixaban in healthy subjects. (December 2013)

7. Effect of ketoconazole and diltiazem on the pharmacokinetics of apixaban, an oral direct factor Xa inhibitor. (May 2015)

9. Evaluation of the effect of naproxen on the pharmacokinetics and pharmacodynamics of apixaban. (October 2014)

10. Factors associated with early outcomes following standardised therapy in children with ulcerative colitis (PROTECT): a multicentre inception cohort study. (December 2017)